16:11:07 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-02-29 Bokslutskommuniké 2023
2023-11-23 Kvartalsrapport 2023-Q3
2023-08-25 Kvartalsrapport 2023-Q2
2023-06-30 Årsstämma 2023
2023-05-31 Kvartalsrapport 2023-Q1
2023-05-05 Ordinarie utdelning RLS 0.00 SEK
2023-02-28 Bokslutskommuniké 2022
2023-02-09 Extra Bolagsstämma 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning RLS 0.00 SEK
2022-05-19 Årsstämma 2022
2022-05-11 Kvartalsrapport 2022-Q1
2022-02-25 Bokslutskommuniké 2021
2021-11-12 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-06-17 Årsstämma 2021
2021-05-27 Ordinarie utdelning RLS 0.00 SEK
2021-05-07 Kvartalsrapport 2021-Q1
2021-02-10 Bokslutskommuniké 2020
2020-11-12 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-05-27 Ordinarie utdelning RLS 0.00 SEK
2020-05-26 Årsstämma 2020
2020-05-15 Kvartalsrapport 2020-Q1
2020-02-14 Bokslutskommuniké 2019
2019-11-15 Kvartalsrapport 2019-Q3
2019-08-19 Extra Bolagsstämma 2019
2019-08-15 Kvartalsrapport 2019-Q2
2019-05-31 Ordinarie utdelning RLS 0.00 SEK
2019-05-29 Årsstämma 2019
2019-05-15 Kvartalsrapport 2019-Q1
2019-02-28 Bokslutskommuniké 2018
2018-11-30 Kvartalsrapport 2018-Q3
2018-08-31 Kvartalsrapport 2018-Q2
2018-06-14 Ordinarie utdelning RLS 0.00 SEK
2018-06-13 Årsstämma 2018
2018-05-31 Kvartalsrapport 2018-Q1
2018-02-28 Bokslutskommuniké 2017
2017-11-28 Kvartalsrapport 2017-Q3
2017-11-15 Extra Bolagsstämma 2017
2017-08-31 Kvartalsrapport 2017-Q2
2017-06-09 Ordinarie utdelning RLS 0.00 SEK
2017-06-08 Årsstämma 2017
2017-05-31 Kvartalsrapport 2017-Q1
2017-02-20 Bokslutskommuniké 2016
2016-11-30 Kvartalsrapport 2016-Q3
2016-08-31 Kvartalsrapport 2016-Q2
2016-06-01 Ordinarie utdelning RLS 0.00 SEK
2016-05-31 Kvartalsrapport 2016-Q1
2016-05-31 Årsstämma 2016
2016-02-29 Bokslutskommuniké 2015
2016-01-21 Extra Bolagsstämma 2016
2015-11-30 Kvartalsrapport 2015-Q3
2015-08-31 Kvartalsrapport 2015-Q2
2015-06-12 Ordinarie utdelning RLS 0.00 SEK
2015-06-11 Årsstämma 2015
2015-05-28 Kvartalsrapport 2015-Q1
2015-02-27 Bokslutskommuniké 2014
2014-11-28 Kvartalsrapport 2014-Q3
2014-09-12 Extra Bolagsstämma 2014
2014-08-29 Kvartalsrapport 2014-Q2
2014-06-10 Ordinarie utdelning RLS 0.00 SEK
2014-06-09 Årsstämma 2014
2014-05-23 Kvartalsrapport 2014-Q1
2014-03-05 Bokslutskommuniké 2013
2013-11-29 Kvartalsrapport 2013-Q3
2013-09-04 Kvartalsrapport 2013-Q2
2013-05-31 Kvartalsrapport 2013-Q1
2013-05-08 Split RLS 10:1
2013-04-11 Ordinarie utdelning RLS 0.00 SEK
2013-04-10 Årsstämma 2013
2013-03-05 Bokslutskommuniké 2012
2012-11-26 Kvartalsrapport 2012-Q3
2012-08-31 Kvartalsrapport 2012-Q2
2012-06-12 Ordinarie utdelning RLS 0.00 SEK
2012-06-11 Årsstämma 2012

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
RLS Global är verksamma inom bioteknik. Bolaget utvecklar biokemiska produkter och metoder för behandling av förekommande sår hos patienter. Bolagets produkter angriper skadad vävnad via den egenutvecklade teknologin som baseras på hypoklorit. Idag bedrivs forskning och utveckling inom vävnadsbaserad teknik. Bolaget har sitt huvudkontor i Göteborg.
2022-02-25 09:00:00
OCTOBER 1[st ]- DECEMBER 31[st] (previous year in brackets)
  • Net sales amounted to TSEK 219 (TSEK 139)
  • Earnings before interest and taxes (EBIT) amounted to TSEK -7 478 (TSEK -7 655)
  • Earning per share before dilution at SEK -0,11 (SEK -0,12)
  • Cash flow from operating activities amounted to TSEK -4 887 (TSEK -7 000)
  • Liquid assets at the end of the period TSEK 11 469 (TSEK 18 997)
  • Equity ratio was 75 % (87 %).

 

JANUARY 1[st ]- DECEMBER 31[st] (previous year in brackets)
  • Net sales amounted to TSEK 653 (TSEK 2 043)                     
  • Earnings before interest and taxes (EBIT) amounted to TSEK -11 021 (TSEK -22 458)          
  • Earning per share before dilution at SEK -0,17 (SEK -0,34)                              
  • Cash flow from operating activities amounted to TSEK -8 353 (TSEK -22 219)                         
  • Liquid assets at the end of the period TSEK 11 469 (TSEK 18 997)
  • Equity ratio was 75 % (87 %).

 

SUMMARY OF EVENTS DURING FOURTH QUARTER
  • Activities in order to receive reimbursement in the European countries continue.
The Netherlands are approved.                                                                                                                                                   
  • The collaboration with ConvaTec is progressing according to plan and several training sessions have been completed together with RLS.
  • The automatization project, aiming to lower the COGS of ChloraSolv and to secure
a sustainable production is moving forward.
  • RLS has received the first order for ChloraSolv from ConvaTec.
  • RLS received a guaranteed bridgeloan from one of the main owners.
COVID-19
  • As throughout the year 2021, during the fourth quarter it has been challenging to arrange physical meetings with the healthcare sector. We look forward to meeting customers physically again.

 

TRADING PLACE AND CERTIFIED ADVISER
RLS Global's shares have been listed on the Nasdaq First North Growth Market since 17[th] May, 2017 and trading takes place under the short name RLS. Certified Adviser is Redeye Aktiebolag, phone: +46 8 121 576 90, email: certifiedadviser@redeye.se.During the period 2012-2017, the company was listed on Aktietorget.

The Year-end Report Q4, 2021, is enclosed and is also available here:
https://rls.global/wp-content/uploads/2022/02/RLS_Global_Q4_2021_EN.pdf

PUBLICATION
This information was submitted for publication through the agency of the below contact person, at 09.00 CET on Feb 25[th] 2022.